Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients.
Tamoxifen is used to prevent and treat estrogen-dependent breast cancer. It is described as a prodrug since most of its antiestrogen effects are exerted through its hydroxylated metabolites 4-OH-tamoxifen and endoxifen. In prior work, we correlated optimal plasma levels of these metabolites with cer...
Main Authors: | Alicia Romero-Lorca, Apolonia Novillo, María Gaibar, Fernando Bandrés, Ana Fernández-Santander |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4503404?pdf=render |
Similar Items
-
Implication of human UGT2B7, 2B15 and 2B17 in 19-norandrosterone metabolism
by: Emmanuel eStrahm, et al.
Published: (2013-06-01) -
Red wine and component flavonoids inhibit UGT2B17 <it>in vitro</it>
by: Jenkinson Carl, et al.
Published: (2012-09-01) -
Regulation of Hepatic UGT2B15 by Methylation in Adults of Asian Descent
by: Steffen G. Oeser, et al.
Published: (2018-01-01) -
Polymorphisms of estrogen metabolism-related genes ESR1 , UGT2B17 , and UGT1A1 are not associated with osteoporosis in artificial menopausal Japanese women
by: Megumi Yokota, et al.
Published: (2015-09-01) -
Complete Reaction Phenotyping of Propranolol and 4-Hydroxypropranolol with the 19 Enzymes of the Human UGT1 and UGT2 Families
by: Fan Yang, et al.
Published: (2022-07-01)